GX-19
Vaccine candidate against COVID-19 / From Wikipedia, the free encyclopedia
GX-19 is a COVID-19 vaccine candidate developed by Genexine consortium.[1][2][3][4]
Quick Facts Vaccine description, Target ...
Vaccine description | |
---|---|
Target | SARS-CoV-2 |
Vaccine type | DNA |
Clinical data | |
Other names | GX-19N |
Routes of administration | Intramuscular |
Identifiers | |
DrugBank |
Close
It is a DNA-based vaccine that encodes the SARS-CoV-2 spike protein.[5]